Cite
Kasalak Ö, Suurmeijer AJH, De Haan JJ, et al. A Pitfall for Diffusion-weighted MR Imaging When Assessing the Response to Neoadjuvant Chemotherapy in Ewing Sarcoma. Magn Reson Med Sci. 2018;18(4):249-250doi: 10.2463/mrms.ci.2018-0122.
Kasalak, �. �., Suurmeijer, A. J. H., De Haan, J. J., Adams, H. J. A., Jutte, P. C., Kwee, T. C., Ow, S. H., Cheong, L. S., & Thong, M. K. (2019). A Pitfall for Diffusion-weighted MR Imaging When Assessing the Response to Neoadjuvant Chemotherapy in Ewing Sarcoma. Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine, 18(4), 249-250. https://doi.org/10.2463/mrms.ci.2018-0122
Kasalak, Ömer, et al. "A Pitfall for Diffusion-weighted MR Imaging When Assessing the Response to Neoadjuvant Chemotherapy in Ewing Sarcoma." Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine vol. 18,4 (2019): 249-250. doi: https://doi.org/10.2463/mrms.ci.2018-0122
Kasalak Ö, Suurmeijer AJH, De Haan JJ, Adams HJA, Jutte PC, Kwee TC, Ow SH, Cheong LS, Thong MK. A Pitfall for Diffusion-weighted MR Imaging When Assessing the Response to Neoadjuvant Chemotherapy in Ewing Sarcoma. Magn Reson Med Sci. 2019 Oct 15;18(4):249-250. doi: 10.2463/mrms.ci.2018-0122. Epub 2018 Dec 06. PMID: 30518735; PMCID: PMC6883089.
Copy
Download .nbib